Prior Report Recap In Sophic Capital’s Promising COVID-19 News, But Health Threat Remains report, we discussed: Recent advances in the battle against COVID-19 that propelled the markets higher; An examination of Pfizer/BioNTech’s phase 3 vaccine trials, and why...
Recent Advances in the Battle Against COVID-19 The world breathed a collective sigh of relief at Pfizer and BioNTech’s announcement of a COVID-19 vaccine candidate passing phase 3 trials. In response, the markets roared on November 9, 2020 with a massive rotation from...
—Kontrol BioCloud is a Safe Space Technology™— COVID-19 Mortality in Children is Low, But Long-Term Health Issues Can Persist The coronavirus pandemic has wreaked havoc on our lives, livelihoods, and economies. Worse, one million people have died from...
We thought it would be a good idea to catch up with Paul Ghezzi, CEO of Kontrol Energy (CSE:KNR; OTC:KNRLF) and the recent BioCloud technology announcements. Q. Why the focus on COVID-19 with the BioCloud technology and more importantly, how does it relate to your...
The Bridge to A Vaccine or Treatment COVID-19 Vaccine Hype a ‘Grave Disservice’ to the Public “Grave Disservice” are the words of Merck & Co (NYSE:MRK) CEO Ken Frazier, during a July 2020 interview with Harvard Business School. We at Sophic...
A High Growth ESG Sector that is Rapidly Consolidating Two Problems Creating a $100 Billion Annual Opportunity in North America Problem #1: North American buildings waste up to 30% of the energy they consume due to lack of intelligence and technology. Problem #2: Ask...
